|
XRCC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.15463194561016E-14 |
| Normal-vs-Stage2 |
1.202870E-04 |
| Normal-vs-Stage3 |
4.27520019385952E-10 |
| Normal-vs-Stage4 |
1.32359999960308E-07 |
| Stage1-vs-Stage2 |
8.882200E-01 |
| Stage1-vs-Stage3 |
2.347800E-01 |
| Stage1-vs-Stage4 |
2.163700E-02 |
| Stage2-vs-Stage3 |
3.785400E-01 |
| Stage2-vs-Stage4 |
4.404400E-02 |
| Stage3-vs-Stage4 |
1.428650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
4.49169999999777E-05 |
| Normal-vs-Asian |
8.962400E-02 |
| Caucasian-vs-AfricanAmerican |
7.938100E-03 |
| Caucasian-vs-Asian |
4.459400E-01 |
| AfricanAmerican-vs-Asian |
2.528200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-16 |
| Normal-vs-Female |
3.8746783559418E-14 |
| Male-vs-Female |
9.305200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.739190E-03 |
| Normal-vs-Age(41-60Yrs) |
1.40443212615082E-13 |
| Normal-vs-Age(61-80Yrs) |
7.88258347483861E-15 |
| Normal-vs-Age(81-100Yrs) |
6.971000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.719000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.889160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.258960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.947200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.805600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.942400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.41930000000057E-05 |
| Normal-vs-Grade 2 |
2.8199664825479E-14 |
| Normal-vs-Grade 3 |
1.19237952844742E-13 |
| Normal-vs-Grade 4 |
1.42520000001589E-06 |
| Grade 1-vs-Grade 2 |
8.891400E-01 |
| Grade 1-vs-Grade 3 |
6.239000E-01 |
| Grade 1-vs-Grade 4 |
5.712400E-02 |
| Grade 2-vs-Grade 3 |
5.458200E-01 |
| Grade 2-vs-Grade 4 |
3.814000E-02 |
| Grade 3-vs-Grade 4 |
7.076000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.42885703269258E-13 |
| Normal-vs-ccB subtype |
2.79776202205539E-13 |
| ccA subtype-vs-ccB subtype |
1.050050E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.68021152546771E-12 |
| Normal-vs-N1 |
2.944800E-03 |
| N0-vs-N1 |
9.318300E-02 |
|
|
